Physician profile
Scott J Pollak
NPI 1629062245
$12,204.12
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $121 · 2021: $114 · 2022: $304 · 2023: $350 · 2024: $66.87.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $204 · Food and Beverage: $198 · Consulting Fee: $15.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $203.99 |
| Food and Beverage | $197.68 |
| Consulting Fee | $15.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $7,903.99 | 2019-2023 | Carto 3 |
| Biosense Webster, INC. | $3,364.34 | 2019 | |
| Abbott Laboratories | $267.87 | 2020-2022 | |
| Medtronic Vascular, INC. | $183.63 | 2019-2020 | |
| Astellas Pharma US INC | $99.99 | 2021 | |
| Irhythm Technologies, INC. | $70.26 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $70.10 | 2021-2024 | Eliquis |
| Merck Sharp & Dohme LLC | $50.82 | 2022-2023 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $44.04 | 2022-2023 | Jardiance |
| Novo Nordisk INC | $24.05 | 2024 | Wegovy |
| Impulse Dynamics (USA) INC. | $21.05 | 2022 | |
| Novartis Pharmaceuticals Corporation | $19.95 | 2023 | |
| Lexicon Pharmaceuticals, INC. | $19.31 | 2023 | Inpefa |
| Pfizer INC. | $18.14 | 2022 | |
| Vital Connect, INC | $17.98 | 2023 | Vitalpatch Rtm |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $15.00 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Ge Healthcare | $13.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Pollak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.